These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10839656)

  • 21. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.
    Lafeuillade A; Poggi C; Chadapaud S; Hittinger G; Chouraqui M; Pisapia M; Delbeke E
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):44-55. PubMed ID: 11176268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS).
    Serafini S; Fraternale A; Rossi L; Casabianca A; Antonelli A; Paoletti MF; Orlandi C; Pierigè F; Sfara C; Schiavano GF; Magnani M
    Antiviral Res; 2009 Feb; 81(2):93-102. PubMed ID: 18977391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.
    Ohnota H; Okada Y; Ushijima H; Kitamura T; Komuro K; Mizuochi T
    Antimicrob Agents Chemother; 1990 Apr; 34(4):605-9. PubMed ID: 1693056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome.
    Phillips NC; Tsoukas C
    Blood; 1992 Mar; 79(5):1137-43. PubMed ID: 1371411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 3'azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS.
    Eiseman JL; Yetter RA; Fredrickson TN; Shapiro SG; MacAuley C; Bilello JA
    Antiviral Res; 1991 Dec; 16(4):307-26. PubMed ID: 1663732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS.
    Klinman DM; Krieg A; Conover J; Ussery MA; Black PL
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant reduction in HIV-1 plasma viral load but not in proviral infected cells during sub-optimal antiretroviral therapy.
    Riva E; Antonelli G; Solmone MC; Turriziani O; Narciso P; Tozzi V; Dianzani F
    J Biol Regul Homeost Agents; 2000; 14(1):1-3. PubMed ID: 10763882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice.
    Chow HH; Li P; Brookshier G; Tang Y
    Drug Metab Dispos; 1997 Apr; 25(4):412-22. PubMed ID: 9107539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclosporin A and zidovudine on immune abnormalities observed in the murine acquired immunodeficiency syndrome.
    Cerny A; Merino R; Fossati L; de Kossodo S; Heusser C; Waldvogel FA; Morse HC; Izui S
    J Infect Dis; 1992 Aug; 166(2):285-90. PubMed ID: 1634800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
    Basham T; Holdener T; Merigan T
    J Infect Dis; 1991 Apr; 163(4):869-72. PubMed ID: 1849164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387.
    Sklan EH; Gazit A; Priel E
    Virology; 2000 Dec; 278(1):95-102. PubMed ID: 11112485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease.
    Specter S; Plotnikoff N; Bradley WG; Goodfellow D
    Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of murine AIDS by reduced glutathione.
    Palamara AT; Garaci E; Rotilio G; Ciriolo MR; Casabianca A; Fraternale A; Rossi L; Schiavano GF; Chiarantini L; Magnani M
    AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1373-81. PubMed ID: 8891117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes.
    Lafeuillade A; Tamalet C; Poggi C; Pellegrino P; Tourres C; Izopet J
    AIDS; 1997 Jan; 11(1):67-72. PubMed ID: 9110077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Désormeaux A; Gourde P; Tremblay M; Beauchamp D; Bergeron MG
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):451-61. PubMed ID: 8757421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.
    Perrin L; Yerly S; Marchal F; Schockmel GA; Hirschel B; Fox CH; Pantaleo G
    J Infect Dis; 1998 Jun; 177(6):1497-501. PubMed ID: 9607825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
    Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S
    J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.